Illumina, Inc. (ILMN) FY2026 YTD Q2 P&L / Income Statement

Illumina, Inc. (ILMN) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2025-12-29 through 2026-06-28. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

2,251,000,000 US dollars

Total cost of revenue

760,000,000 US dollars

Gross profit

1,491,000,000 US dollars

Total operating expense

1,037,000,000 US dollars

Income from operations

454,000,000 US dollars

Total other income (expense), net

negative 37,000,000 US dollars

Income before income taxes

417,000,000 US dollars

Provision for income taxes

77,000,000 US dollars

Net income

340,000,000 US dollars

Microarray - Consumables

149,000,000 US dollars

Microarray - Instruments

7,000,000 US dollars

Microarray - Service

46,000,000 US dollars

Sequencing - Consumables

1,500,000,000 US dollars

Sequencing - Instruments

243,000,000 US dollars

Sequencing - Service

306,000,000 US dollars

Research and development

492,000,000 US dollars

Selling, general and administrative

545,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.